Joanne Holland
Vermögen: 84 000 $ am 31.08.2026
Vermögen: 84 000 $ am 31.08.2026
Joanne Holland was the founder of Nuformix Plc, founded in 2008, serving as Executive Director in 2021.
Dr. Holland is currently the Chief Scientific Officer at CDT Equity, Inc., starting in 2024.
Formerly, Director, Chief Scientific & Technology Officer at Nuformix Technologies Ltd. from 2008 to 2021.
Education includes a doctorate from the University of Leeds.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NUFORMIX PLC 1,44 % | 28.01.2025 | 37 500 000 ( 1,44 % ) | 84 000 $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| CDT EQUITY INC. | Technik-/Wissenschafts-/F&E-Leiter | 19.03.2024 |
| Unternehmen | Position | Ende |
|---|---|---|
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | 31.05.2021 |
| NUFORMIX PLC | Gründer | 31.05.2021 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 4 |
|---|---|
University of Leeds
University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Nuformix Plc
Nuformix Plc BiotechnologyHealth Technology Develops commercial technologies in pharmaceutical and biotechnology sector | Health Technology |
Conduit Pharmaceuticals, Inc.
Conduit Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage specialty biopharmaceutical company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen